A Pilot Study of Active Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer

Trial Profile

A Pilot Study of Active Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 29 Jun 2017

At a glance

  • Drugs AVX 701 (Primary)
  • Indications Colon cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 25 Jun 2017 Status changed from recruiting to active, no longer recruiting.
    • 05 Aug 2016 Planned End Date changed from 1 Nov 2017 to 1 Nov 2018.
    • 11 Jan 2014 Planned End Date changed from 1 Aug 2017 to 1 Nov 2017 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top